AMLX•benzinga•
Amylyx Pharmaceuticals Announced That The First Participant Has Been Dosed In LUMINA, Phase 1, Multinational, Randomized, Double-blind, Placebo-controlled, Multiple Ascending Dose Clinical Trial Of AMX0114 In People Living With Amyotrophic Lateral Scleros
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 9, 2025 by benzinga